2021 research period for North America is officially open
March 24, 2021
Research team is now accepting firm submissions, due June 1
US
General Patent Litigation
| General Patent Litigation — Recommended |
|---|
| Arnold & Porter |
| Cooley |
| Covington & Burling |
| Durie Tangri |
| Gibson Dunn & Crutcher |
| Knobbe Martens |
| Mayer Brown |
| McAndrews Held & Malloy |
| Morgan Lewis & Bockius |
| Sterne Kessler Goldstein & Fox |
| Venable |
| Weil Gotshal & Manges |
Hatch-Waxman Patent Litigation (Generic)
| Hatch-Waxman Patent Litigation (Generic) — Highly Recommended |
|---|
| Goodwin Procter |
| Knobbe Martens |
| Rakoczy Molino Mazzochi Siwik |
| Sterne Kessler Goldstein & Fox |
| Wilson Sonsini Goodrich & Rosati |
| Winston & Strawn |
| Hatch-Waxman Patent Litigation (Generic) — Recommended |
|---|
| Axinn Veltrop & Harkrider |
| Greenberg Traurig |
| Morrison & Foerster |
| Perkins Coie |
| Robins Kaplan |
| Rothwell Figg Ernst & Manbeck |
| Taft Stettinius & Hollister |
| Willkie Farr & Gallagher |
Patent Prosecution
Patent Strategy & Management
| Patent Strategy & Management — Recommended |
|---|
| Arnold & Porter |
| Dechert |
| Fenwick & West |
| Foley & Lardner |
| Greenberg Traurig |
| Hamilton Brook Smith & Reynolds |
| Leydig Voit & Mayer |
| McDonnell Boehnen Hulbert & Berghoff |
| Morgan Lewis & Bockius |
| Venable |
| WilmerHale |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Altman, Dan | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Irvine |
| Fuller, Michael | Intellectual Property | Patent Strategy & Management | San Diego |
| Lea, Christy G | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | Irvine |
| Lee, Sabing | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Irvine |
| Mallon, Joseph | Intellectual Property | Patent Strategy & Management | San Diego |
| Merani, Salima | Intellectual Property | Patent Prosecution, Patent Strategy & Management | Irvine |
| Miller, Kimberly | Intellectual Property | Patent Prosecution, Patent Strategy & Management, Hatch-Waxman Patent Litigation | San Diego |
| Re, Joseph | Intellectual Property | General Patent Litigation | Irvine |
| Reisman, Joseph | Intellectual Property | Patent Prosecution, Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | San Diego |
| Sganga, John | Intellectual Property | General Patent Litigation | Irvine |
| Swaroop, Sheila | Intellectual Property | General Patent Litigation | Irvine |
| von Hoffmann, Gerard | Intellectual Property | Patent Strategy & Management | San Diego |
| Zimmerman, William | Intellectual Property | Patent Strategy & Management, General Patent Litigation, Hatch-Waxman Patent Litigation | Washington, D.C. |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Knobbe Martens
IP firm Knobbe Martens earns national ranking across all areas in IP, including top-tier status in generic Hatch-Waxman litigation, patent prosecution and strategy. "Knobbe has done everything right for our firm," a client says. "This is a remarkable firm [with] spectacular work and people."
Co-chair of the Hatch-Waxman and life sciences groups William Zimmerman contributes to the firm's leading status as a destination for generic pharmaceutical representation. Trial lawyer Joseph Re has more than three decades of experience in law and has handled matters across technology areas, most notably in the medical device industry. He was recently active for Personal Genome Diagnostics in a closely watched dispute. Medical device litigation co-chair Christy Lea is experienced in jury trials, appeals and post-grant proceedings. Fellow co-chair John Sganga offers deep experience in device patent litigation, showcased by a recent, global matter for Edwards Lifesciences against Boston Scientific.
Gerard von Hoffmann is a go-to patent strategist for clients in the medical device industry. He recently assisted Millipede Inc in its $450 million acquisition by Boston Scientific. Salima Merani has deep expertise in patent strategy, often connected to complex transactions and corporate matters. Biotechnology group chair Michael Fuller specializes in strategic patent counseling and portfolio management. He was recently involved in the above matter for Illumina against Natera.